Anti-diabetes drugs may reduce the risk of colorectal cancer
People with diabetes who took drugs called GLP-1 receptor agonists had a lower risk of colorectal cancer compared with those prescribed other diabetes drugs.
Source: NIH Research Matters from the National Institutes of Health (NIH) - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Diabetes | Endocrinology | Health | National Institutes of Health (NIH)